Skip to main content

RAMPART TRIAL-Rapid Anticonvulsant Medication Prior to Arrival Trial


The RAMPART Trial

Status epilepticus is a life-threatening medical emergency that occurs when a seizure lasts for more than 5 minutes or when there are multiple seizures without a return to consciousness in between. It is important to treat status epilepticus as quickly as possible, as the longer it goes untreated, the greater the risk of brain damage and death.

The RAMPART trial (Rapid Anticonvulsant Medication Prior to Arrival Trial) was a randomized clinical trial that compared the efficacy of intramuscular (IM) midazolam to intravenous (IV) lorazepam in the prehospital treatment of status epilepticus. The trial enrolled 1,080 adults and children with status epilepticus who were treated by paramedics.

The primary outcome of the trial was the proportion of patients who had seizure cessation within 10 minutes of receiving the first dose of medication. The secondary outcomes included the proportion of patients who had seizure cessation within 20 minutes, 30 minutes, and 60 minutes of receiving the first dose of medication, as well as the proportion of patients who had a favorable outcome at 24 hours.



The results of the RAMPART trial showed that IM midazolam was noninferior to IV lorazepam for the primary outcome of seizure cessation within 10 minutes. The proportion of patients who had seizure cessation within 10 minutes was 73% in the IM midazolam group and 63% in the IV lorazepam group.

The RAMPART trial also showed that IM midazolam was associated with a faster time to seizure cessation than IV lorazepam. The median time to seizure cessation was 3.3 minutes in the IM midazolam group and 1.6 minutes in the IV lorazepam group.

The results of the RAMPART trial suggest that IM midazolam is a safe and effective treatment for status epilepticus in the prehospital setting. IM midazolam is also faster acting than IV lorazepam, which could lead to better outcomes for patients with status epilepticus.

The findings of the RAMPART trial have been incorporated into the American Epilepsy Society's guidelines for the treatment of status epilepticus. The guidelines recommend that IM midazolam be used as the first-line treatment for status epilepticus in the prehospital setting.

New Treatments for Seizure Control

In addition to IM midazolam, there are a number of other new treatments for seizure control that are being developed. These include:

  • Percept PC: This is a deep brain stimulation device that is approved by the FDA for the treatment of epilepsy. The device is implanted in the thalamus, a part of the brain that is involved in controlling seizures.
  • Epilepsy vaccines: These are vaccines that are designed to prevent seizures. Epilepsy vaccines are still in the early stages of development, but they have the potential to revolutionize the treatment of epilepsy.
  • Gene therapy: Gene therapy is a technique that involves replacing or repairing defective genes. Gene therapy is being investigated as a potential treatment for a number of diseases, including epilepsy.

The development of new treatments for seizure control is a promising area of research. These new treatments have the potential to improve the quality of life for people with epilepsy and to reduce the risk of death from status epilepticus.

Labels:

Comments

Post a Comment

Popular posts from this blog

Various Methods of Shoulder Joint Reduction

  Shoulder joint dislocation can be reduced by a lot of explained maneuvers. Its better to learn them through some good videos from open source (YouTube and Vimeo) rather than memorizing  The various maneuvers for the reduction of a Dislocated Shoulder Joint are     1. Kochers Maneuver     2. FARES (Fast Reliable and Safe Technique)     3. Hennepin Technique (External Rotation Technique)     4. Milch Technique     5. Stimsons Technique (Gravitational Weight)     6. Hippodratic and Modified Hippocratic Technique     7. Cunningham Technique Kochers Maneuver Adduction-ExtRotation-Flexion-Internal Rotation The process must be very slow and its better to give some muscle relaxant and analgesic prior to the procedure. Cunningham Technique https://www.youtube.com/watch?v=HGIjEEg_PQQ FARES (FAst, REliable and Safe Technique) Small occilating movements while in extension and external rotation. Gradually this is incre...
Post a Comment
Read more

Febrile Neutropenia: Succinct Guide

Febrile Neutropenia Definition Febrile neutropenia (FN) is a medical emergency characterized by the development of fever in a patient with significant neutropenia. It is commonly seen in immunocompromised individuals, particularly those undergoing chemotherapy for malignancies. Diagnostic Criteria Febrile neutropenia is defined by the following criteria: Fever : A single oral temperature ≥ 38.3°C (101°F) or a sustained temperature ≥ 38.0°C (100.4°F) for more than 1 hour. Neutropenia : An absolute neutrophil count (ANC) < 500 cells/μL, or expected to fall below 500 cells/μL within 48 hours. Etiology and Major Causes The primary cause of febrile neutropenia is chemotherapy-induced myelosuppression. Other causes include: Hematological malignancies (e.g., leukemia, lymphoma, myelodysplastic syndromes) Bone marrow suppression due to radiation therapy Aplastic anemia and other bone marrow disorders Infections : Bacterial (Gram-negative and Gram-positive), fungal, and viral infections Dru...
Post a Comment
Read more

Recent Trials on Balanced Crystalloid Solutions vs. Conventional Intravenous Fluids

Intravenous (IV) fluids are a cornerstone of modern medicine, used extensively in hospitals for resuscitation, maintenance, and replacement therapy. Normal saline (0.9% sodium chloride) has been the most commonly used IV fluid worldwide for decades. However, recent research has raised concerns about its potential adverse effects, particularly its high chloride content, which can lead to hyperchloremic acidosis and kidney injury.  In response, balanced crystalloid solutions, such as lactated Ringer's and Plasma-Lyte, have gained attention as potentially safer alternatives. This article explores the findings of recent trials comparing balanced crystalloids to conventional IV fluids.  While widely used the problem with Normal Saline is that it has a chloride concentration significantly higher than that of human plasma. This can disrupt the body's acid-base balance, leading to hyperchloremic metabolic acidosis, a condition associated with renal vasoconstriction, reduced glome...
Post a Comment
Read more